A common constipation drug shows surprising power to protect kidneys

A common constipation drug may have unexpectedly unlocked a new way to slow chronic kidney disease — a condition that affects millions and often leads to dialysis. In a clinical trial involving 150 patients, researchers found that lubiprostone, a medication normally used to treat constipation, helped preserve kidney function in people with moderate CKD. Scientists traced the effect to changes in gut bacteria that boosted production of spermidine, a compound linked to healthier mitochondria and reduced kidney damage.

from Latest Science News -- ScienceDaily https://ift.tt/U5Q8Gde

Comments

Post a Comment

Popular posts from this blog

Single psilocybin trip delivers two years of depression relief for cancer patients

Psilocybin, the active ingredient in magic mushrooms, might just revolutionize how depression and anxiety are treated in cancer patients. In a groundbreaking trial, a single dose combined with therapy significantly reduced emotional suffering, and these effects often lasted over two years. As follow-up studies expand the research to multiple doses and larger samples, scientists are eyeing a possible new standard of care that merges psychedelics with psychological support. from Latest Science News -- ScienceDaily https://ift.tt/P1Aoby3
Read more